Related Experiment Video
Updated: Jun 12, 2025

Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
Systematic bacteriophage selection for the lysis of multiple Pseudomonas aeruginosa strains
Finja Rieper1,2, Johannes Wittmann3, Boyke Bunk3
1Pharmaceutical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Braunschweig, Germany.
Abstract:
Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections of the lung, burn wounds and eyes. Due to its intrinsic high antibiotic resistance the bacterium is difficult to eradicate. A promising therapeutic option is the use of P. aeruginosa-specific bacteriophages. Thus, the implementation of a phage therapy requires their selection, production and systematic administration using multiple strains of the bacterial target. Here, we used 25 phages and tested their susceptibility on 141 different P. aeruginosa strains isolated from patients with different types of infection. Comparative host spectrum analyses were carried out using double agar overlay plaque assay (DPA) and planktonic killing assay (PKA), which resulted in 70% of the cases in the same host range. All phages were assigned to known phage genera, but some of the phages are new species. Isolated members of the genera Pakpunavirus, Pbunavirus (myoviruses), Pawinskivirus, Elvirus (myoviruses, jumbo phages), Litunavirus and Bruynoghevirus (podoviruses) demonstrated great therapeutic potential due to strong lysis behavior on diverse strains. Seven phages were excluded for therapeutic purposes due to genetic determinants that confer lysogenicity. Due to automation with lower time expenditure in execution and analysis, PKA has the higher potential for implementation in diagnostics. Finally, different combinations of phages were tested in silico with various P. aeruginosa strains. Highly efficient phage combinations eradicating multiple P. aeruginosa strains were found. Thus, a solid basis for the development of a broad host range phage therapy was laid.
Insights
This study explored bacteriophages to treat antibiotic-resistant Pseudomonas aeruginosa infections. Researchers identified effective phage combinations, laying the groundwork for developing broad-spectrum phage therapy against this pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Biotechnology
Background:
- Pseudomonas aeruginosa is a highly antibiotic-resistant opportunistic pathogen causing severe infections.
- Phage therapy, using P. aeruginosa-specific bacteriophages, presents a promising alternative to antibiotics.
- Effective phage therapy requires careful selection, production, and administration of multiple phage strains.
Purpose of the Study:
- To evaluate the efficacy of 25 bacteriophages against 141 clinical isolates of Pseudomonas aeruginosa.
- To compare host spectrum analyses using double agar overlay plaque assay (DPA) and planktonic killing assay (PKA).
- To identify potent phage combinations for broad-spectrum therapeutic application against P. aeruginosa.
Main Methods:
- Susceptibility testing of 25 phages against 141 P. aeruginosa strains using DPA and PKA.
- Classification of phages into known genera and identification of potential new species.
- Exclusion of phages with lysogenic potential.
- In silico analysis of phage combinations for synergistic efficacy.
Main Results:
- DPA and PKA yielded concordant host range results in 70% of cases, with PKA showing higher potential for diagnostics due to automation.
- Several phage genera, including Pakpunavirus, Pbunavirus, Pawinskivirus, Elvirus, Litunavirus, and Bruynoghevirus, demonstrated significant lytic activity.
- Seven phages were disqualified due to the presence of genetic determinants for lysogenicity.
- In silico testing identified highly effective phage combinations capable of eradicating multiple P. aeruginosa strains.
Conclusions:
- Bacteriophage therapy is a viable strategy for combating antibiotic-resistant Pseudomonas aeruginosa.
- Planktonic killing assay (PKA) is a suitable high-throughput method for phage diagnostics.
- The identified phage combinations provide a foundation for developing a broad-spectrum phage therapy against P. aeruginosa.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
Antibiotic Selection
Lysogenic Cycle of Bacteriophages

